Pérez-López Faustino R, Villagrasa-Boli Pablo, Muñoz-Olarte María, Morera-Grau Álex, Cruz-Andrés Pablo, Hernandez Adrian V
1 Facultad de Medicina, Universidad de Zaragoza, Red de Investigación en Ginecología, Obstetricia y Reproducción, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
2 Department of Obstetrics and Gynecology, Lozano Blesa University Hospital, Zaragoza, Spain.
Reprod Sci. 2018 Mar;25(3):311-319. doi: 10.1177/1933719117749760. Epub 2018 Jan 5.
To perform a systematic review and meta-analysis to estimate the effect of endometriosis on preterm birth (PB) risk.
Searches were conducted in PubMed-MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, Google Scholar, and SciELO for studies published in all languages from inception through April 2017. We included cohort studies evaluating pregnant women with and without endometriosis and conception either by spontaneous conception (SC) or with assisted reproductive technology (ART). Primary outcome was PB (<37 weeks), and secondary outcomes were intrauterine growth restriction (IUGR), low birthweight, small for gestational age (SGA), and birthweight. Pooled odds ratios (ORs) and its 95% confidence interval (CI) were calculated as effects, and random-effects models were used for meta-analyses. Risk of bias was assessed with the Newcastle-Ottawa Scale, and heterogeneity of effects among studies was described with the I statistic.
We identified 9 cohort studies including a total of 1 496 715 pregnancies (13 798 with endometriosis diagnosis). In women with endometriosis, the PB risk was significantly increased in both SC (OR: 1.59; 95% CI: 1.32-1.90) and ART (OR: 1.43; 95% CI: 1.14-1.79). The SGA risk was increased in women with endometriosis (OR: 1.16; 95% CI: 1.05-1.28), while the IUGR and low birthweight risks and birthweight were not affected by endometriosis.
Endometriosis is associated with increased PB risk in both SC and women who obtained pregnancy using ART. Prospective studies evaluating relevant outcomes are needed to confirm these results.
进行一项系统评价和荟萃分析,以评估子宫内膜异位症对早产风险的影响。
在PubMed-MEDLINE、Embase、Scopus、Web of Science、Cochrane图书馆、谷歌学术和SciELO中进行检索,查找从创刊至2017年4月以所有语言发表的研究。我们纳入了评估患有和未患有子宫内膜异位症的孕妇以及通过自然受孕(SC)或辅助生殖技术(ART)受孕的队列研究。主要结局为早产(<37周),次要结局为宫内生长受限(IUGR)、低出生体重、小于胎龄儿(SGA)和出生体重。计算合并比值比(OR)及其95%置信区间(CI)作为效应量,并使用随机效应模型进行荟萃分析。采用纽卡斯尔-渥太华量表评估偏倚风险,并用I统计量描述研究间效应的异质性。
我们确定了9项队列研究,共纳入1496715例妊娠(13798例被诊断为子宫内膜异位症)。在患有子宫内膜异位症的女性中,自然受孕组(OR:1.59;95%CI:1.32-1.90)和辅助生殖技术组(OR:1.43;95%CI:1.14-1.79)的早产风险均显著增加。患有子宫内膜异位症的女性小于胎龄儿风险增加(OR:1.16;95%CI:1.05-1.28),而宫内生长受限、低出生体重风险和出生体重不受子宫内膜异位症影响。
子宫内膜异位症与自然受孕和通过辅助生殖技术受孕的女性早产风险增加相关。需要进行前瞻性研究评估相关结局以证实这些结果。